Cargando…
Prokineticin Is a New Linker between Obesity and Cardiovascular Diseases
Obesity is a fast growing epidemic event worldwide. Fatness is associated with a number of comorbidities, including cardiovascular diseases (CVDs). Although obesity can be heredity in 30–70% cases, the environmental contributions also play an important role in the increasing prevalence of obesity. T...
Autor principal: | Nebigil, Canan G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388695/ https://www.ncbi.nlm.nih.gov/pubmed/28447033 http://dx.doi.org/10.3389/fcvm.2017.00020 |
Ejemplares similares
-
Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer
por: Nebigil, Canan G., et al.
Publicado: (2023) -
Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside
por: Nebigil, Canan G., et al.
Publicado: (2020) -
Prokineticin Receptor 1 as a Novel Suppressor of Preadipocyte Proliferation and Differentiation to Control Obesity
por: Szatkowski, Cécilia, et al.
Publicado: (2013) -
Targeting GPCRs Against Cardiotoxicity Induced by Anticancer Treatments
por: Audebrand, Anais, et al.
Publicado: (2020) -
Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies
por: Hsu, Po-Yen, et al.
Publicado: (2021)